In conclusion, this study opens up new possibilities for CLDN6 integrated with ferroptosis to predict the prognosis and reveals novel insights into the mechanism by which CLDN6 activates the ferroptosis process in breast cancer. Here, CLDN6 is linked to breast cancer.